
Evotec conducts drug discovery, research and development activities with partners such as academic institutions and pharmaceutical and biotech companies. It operates laboratories in five European countries and the United States, and has built a portfolio of more than 200 proprietary and co-owned R&D projects.
Hamburg, Germany
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.